Search
For optimal search results, please limit to 2 product keywords
If you are searching for information related to a product:
- For optimal results, please enter at least 2 search terms in addition to product name
- Example: [product name] [search term] [search term]
- Example: Product + clinical trials
- For an exact match, please include search terms in double quotations. For example: "Elevatum"
A library of product and clinical information designed to foster scientific exchange.
For optimal search results, please limit to 2 product keywords
If you are searching for information related to a product:
- For optimal results, please enter at least 2 search terms in addition to product name
- Example: [product name] [search term] [search term]
- Example: Product + clinical trials
- For an exact match, please include search terms in double quotations. For example: "Elevatum"
Actively Recruiting Clinical Trials
Immunology
Phase III: Afimkibart in UC (AMETRINE-1)
A Phase III, Multicenter, Double-Blind, Placebo-Controlled, Treat-Through Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With afimkibart (R07790121) in Patients With Moderately to Severely Active Ulcerative Colitis
Oncology
Phase III: Glofitamab in 1L LBCL (SKYGLO)
A Phase III, Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Glofitamab (RO7082859) in Combination With Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma
Oncology
Phase III: Giredestrant in BC (pionERA Breast Cancer (BC))
A Phase III Randomized, Open-Label Study Evaluating Efficacy and Safety of Giredestrant Compared With Fulvestrant, Both Combined With a CDK4/6 Inhibitor, in Patients With Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer With Resistance to Prior Adjuvant Endocrine Therapy
Oncology
Phase III: Divarasib in Metastatic NSCLC (KRASCENDO 1)
A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Patients With Previously Treated KRAS G12C-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Latest Disease State Information
Food Allergy
Food Allergy Disease Education
Learn about food allergies, including anaphylaxis, associated co-morbidities, common symptoms and food allergens.
Neuroscience
Health Equity in Multiple Sclerosis
Become aware of the unmet need to understand multiple sclerosis in black and hispanic populations and the greater burden of disease that they might face.
Oncology
Biomarker Testing in Cancer Care
Discover the integral role that biomarkers play in the clinical management of a patient with cancer and how biomarker testing may detect oncogenic alterations and inform care management.
Oncology
Bispecific Antibodies
Review the role bispecific antibodies may play in tumor cell apoptosis and their interaction with T cells.
Latest Product Information
Indication | Update
Food Allergy
Learn about Genentech’s biologic treatment for Patients with IgE-mediated food allergies.
Indication | Update
Oncology
Review our latest treatment for anaplastic lymphoma kinase (ALK)-positive early-stage lung cancer.
Device | Update
Ophthalmology
Learn about a reintroduction in neovascular age-related macular degeneration (nAMD).
Indication | Update
Rare Blood Disorders
Explore a recently approved treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH).
Resources and Support
Find adverse event reporting information, tools, contact information, and related links, such as patient access.
The information provided on this site is intended for US healthcare professionals only and may include references to a Genentech product or use of a Genentech product that the FDA has not approved. Providing this information should not be construed as a recommendation for use of a Genentech product for unapproved uses.